MarketCap
Intuitive Surgical ISRG
€ 405.01
-3.34%
Facebook
X
Telegram
Intuitive Surgical EV | ISRG
EV Jährlich Intuitive Surgical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 170 B | 203 B | 132 B | 87.3 B | 104 B | 86 B | 66.2 B | 58.1 B | 48.2 B | 26.1 B | 19.9 B | 18.2 B | 16.4 B | 22.7 B | 17.8 B | 1.49 B | 686 M | 1.26 B | 462 M | -34.4 M |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 203 B | -34.4 M | 54 B |
EV anderer Aktien in der Medizinische Instrumente
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
20.4 B | $ 62.37 | -1.79 % | $ 12.4 B |  USA |
 |
OraSure Technologies
OSUR
|
98.2 M | $ 3.44 | 2.08 % | $ 253 M | USA |
 |
ResMed
RMD
|
33.9 B | $ 235.37 | -1.65 % | $ 34.3 B | USA |
 |
Retractable Technologies
RVP
|
85.7 M | $ 0.57 | -0.16 % | $ 17.1 M | USA |
 |
electroCore
ECOR
|
69 M | $ 8.13 | -7.56 % | $ 69 M | USA |
 |
STAAR Surgical Company
STAA
|
895 M | $ 25.2 | -5.69 % | $ 1.25 B | USA |
 |
STERIS plc
STE
|
24 B | $ 252.35 | -0.77 % | $ 24.8 B | USA |
 |
Teleflex Incorporated
TFX
|
8.89 B | $ 151.19 | -0.82 % | $ 6.75 B | USA |
 |
Utah Medical Products
UTMD
|
117 M | $ 72.2 | 1.63 % | $ 234 M | USA |
 |
West Pharmaceutical Services
WST
|
17.9 B | $ 399.94 | 1.94 % | $ 28.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
6.29 B | $ 9.49 | -6.0 % | $ 1.89 B | USA |
 |
InfuSystem Holdings
INFU
|
157 M | $ 13.77 | 1.55 % | $ 284 M | USA |
 |
Repro Med Systems
KRMD
|
201 M | $ 3.09 | 1.98 % | $ 143 M | USA |
 |
Atrion Corporation
ATRI
|
636 M | - | - | $ 810 M | USA |
 |
NeuroMetrix
NURO
|
8.29 M | - | 5.05 % | $ 9.02 M | USA |
 |
AtriCure
ATRC
|
1.55 B | $ 58.53 | -3.89 % | $ 2.79 B | USA |
 |
AngioDynamics
ANGO
|
42.5 M | $ 11.73 | -0.68 % | $ 487 M | USA |
 |
Glaukos Corporation
GKOS
|
7.02 B | $ 221.86 | 0.85 % | $ 12.7 B | USA |
 |
Harvard Bioscience
HBIO
|
78.6 M | $ 8.36 | -1.24 % | $ 371 M | USA |
 |
CRH Medical Corporation
CRHM
|
66.3 M | - | - | $ 282 M | USA |
 |
Microbot Medical
MBOT
|
120 M | $ 1.12 | 4.66 % | $ 51.3 M |  Israel |
 |
Haemonetics Corporation
HAE
|
2.56 B | $ 119.57 | -3.52 % | $ 5.64 B | USA |
 |
Cantel Medical Corp.
CMD
|
726 M | - | -1.18 % | $ 3.4 B | USA |
 |
ICU Medical
ICUI
|
3.36 B | $ 172.2 | 2.71 % | $ 4.24 B | USA |
 |
Milestone Scientific
MLSS
|
27.7 M | $ 0.3 | 1.54 % | $ 24.6 M | USA |
 |
Merit Medical Systems
MMSI
|
5.51 B | $ 87.22 | -2.68 % | $ 5.16 B | USA |
 |
Nephros
NEPH
|
31.3 M | $ 2.83 | -8.32 % | $ 30 M | USA |
 |
Pro-Dex
PDEX
|
199 B | $ 63.04 | 3.01 % | $ 203 B | USA |
 |
Envista Holdings Corporation
NVST
|
3.62 B | $ 25.21 | 1.12 % | $ 4.24 B | USA |
 |
LeMaitre Vascular
LMAT
|
2.73 B | $ 80.99 | -2.99 % | $ 1.83 B | USA |
 |
Pulse Biosciences
PLSE
|
1.64 B | $ 53.16 | 0.16 % | $ 3.58 B | USA |
 |
Repligen Corporation
RGEN
|
6.95 B | $ 173.66 | 3.07 % | $ 9.77 B | USA |
 |
Luminex Corporation
LMNX
|
456 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
631 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
758 M | - | - | $ 955 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
6.3 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
451 M | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
134 M | - | - | $ 28.6 M | USA |
 |
Isoray
ISR
|
29.3 M | - | 0.03 % | $ 108 M | USA |
 |
Masimo Corporation
MASI
|
10.4 B | - | - | $ 9.59 B | USA |
 |
Stereotaxis
STXS
|
191 M | $ 1.11 | 5.71 % | $ 101 M | USA |
 |
Predictive Oncology
POAI
|
-5.62 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
989 M | $ 38.61 | 3.51 % | $ 1.84 B | USA |
 |
Baxter International
BAX
|
21.6 B | $ 25.79 | 0.57 % | $ 13.2 B | USA |
 |
Alcon
ALC
|
50.9 B | $ 74.95 | -2.08 % | $ 37 B |  Schweiz |
 |
iRhythm Technologies
IRTC
|
5.71 B | $ 90.65 | -30.37 % | $ 2.9 B | USA |
 |
Becton, Dickinson and Company
BDX
|
55.5 B | $ 212.61 | -0.66 % | $ 61.2 B | USA |